The total of American health spending is the sum of spending for each individual. And each individual has a spending arc during the course of their live. The average of all these spending arcs can itself be informative. A report from the Society of Actuaries using Health Care Cost Institute and Medicare fee-for-service data examines spending at various ages. (HCCI Report) As might be expected, spending generally rises during each year of life, particularly once adulthood is reached. Male costs are lower than female ones up until about age 55, largely due to childbirth and related expenses. For the Medicare population, costs also rise each year after age 65, although they flatten for males after age 95 and actually decline for females after age 90. Changing demographics–age and gender–account for only about 7 to 10% of the real per capita growth in health spending. The health reform law’s limits on age-adjusting of premiums means that younger people will pay more and older ones less, which means that young people will increasingly subsidize the health spending of older ones. And of course, eliminating a gender rating difference forces males to subsidize female costs. Raising the age for Medicare eligibility would lower overall spending but increase per capita costs. For a person who turns 65, their current estimated out-of-pocket health care costs for their expected remaining life of 20 years would be $146,000. If they lived 25 more years that rises to $220,600. Medicare can expect to pay about $450,000 for a beneficiary turning 65 with 20 years of remaining life expectancy. People with chronic diseases or cancer diagnoses have higher expenses at any age than people without, as might be expected. Now that this basic data set has been created, the effect of various interventions would be interesting to test–looking at cohorts in wellness or disease management programs, looking a people treated in different settings, looking at regional variation.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
Commentary
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
Commentary
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…